| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |